Dr. John Fruehauf on the Best Therapies for Metastatic Melanoma
By Dr. John Fruehauf, Evolent - Last Updated: December 19, 2024DocWire News spoke with Dr. John Fruehauf, field medical director at Evolent, who provided an in-depth overview of the history of treating melanoma, the current treatment paradigm in metastatic melanoma, and about promising trials and therapies on the horizon in this disease space.
Advertisement
Advertisement
Related Posts
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Dr. John Fruehauf details how novel therapies have improved the landscape of metastatic melanoma care.
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
New research has uncovered a combination therapy that shows promising results in melanoma and breast cancer models.
A recent study shows that macrophages can be used to predict whether or not a melanoma patient will respond to chemotherapy.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.